Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $23.04 million. The enterprise value is $15.90 million.

Market Cap	23.04M
Enterprise Value	15.90M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MBRX has 49.50 million shares outstanding. The number of shares has increased by 273.43% in one year.

Current Share Class	49.50M
Shares Outstanding	49.50M
Shares Change (YoY)	+273.43%
Shares Change (QoQ)	+66.17%
Owned by Insiders (%)	2.26%
Owned by Institutions (%)	4.13%
Float	48.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.15

Current Ratio	1.15
Quick Ratio	0.96
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -503.80% and return on invested capital (ROIC) is -276.74%.

Return on Equity (ROE)	-503.80%
Return on Assets (ROA)	-67.42%
Return on Invested Capital (ROIC)	-276.74%
Return on Capital Employed (ROCE)	-185.98%
Revenue Per Employee	n/a
Profits Per Employee	-$1.56M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.68% in the last 52 weeks. The beta is 1.59, so MBRX's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	-81.68%
50-Day Moving Average	0.46
200-Day Moving Average	0.81
Relative Strength Index (RSI)	47.35
Average Volume (20 Days)	4,123,528

Short Selling Information

The latest short interest is 3.92 million, so 7.92% of the outstanding shares have been sold short.

Short Interest	3.92M
Short Previous Month	2.82M
Short % of Shares Out	7.92%
Short % of Float	8.10%
Short Ratio (days to cover)	1.54

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.44M
Pretax Income	-26.55M
Net Income	-26.55M
EBITDA	-25.32M
EBIT	-25.44M
Earnings Per Share (EPS)	-$3.15

Balance Sheet

The company has $7.56 million in cash and $420,000 in debt, giving a net cash position of $7.14 million or $0.14 per share.

Cash & Cash Equivalents	7.56M
Total Debt	420,000
Net Cash	7.14M
Net Cash Per Share	$0.14
Equity (Book Value)	-7.17M
Book Value Per Share	-0.24
Working Capital	1.16M

Cash Flow

Operating Cash Flow	-21.34M
Capital Expenditures	n/a
Free Cash Flow	-21.34M
FCF Per Share	-$0.43

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-273.43%
Shareholder Yield	-273.43%
Earnings Yield	-115.25%
FCF Yield	-92.64%

Analyst Forecast

The average price target for MBRX is $5.00, which is 974.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	974.35%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Mar 22, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1